Evaluation of precursors for the production of a potential Tau imaging agent, 18F-AV-1451

被引：0
|
作者：
Fan, Kuo-Hsien [1 ]
Ogikubo, Junichi [1 ]
Cagnolini, Aldo [1 ]
Xiong, Hui [1 ]
Clemens, Jennifer [1 ]
Hoye, Adam [1 ]
Horchler, Carey L. [1 ]
Li, Ximin [1 ]
Thieu, Tho [1 ]
Ghosh, Shyamali [1 ]
Attardo, Giorgio [1 ]
Lim, Nathaniel [1 ]
机构：
[1] Avid Radiopharmaceut Inc, Philadelphia, PA USA
来源：
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS | 2015年 / 58卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
228
引用
收藏
页码：S228 / S228
页数：1
相关论文
共 50 条
  • [1] Test-Retest Data for the Tau PET Imaging Agent 18F-AV-1451
    Devous, M. D.
    Joshi, A. D.
    Navitsky, M. A.
    Dixon, J.
    Pontecorvo, M. J.
    Siderowf, A.
    Mintun, M. S.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S260 - S260
  • [2] 18F-AV-1451 Tau PET in AD
    不详
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (11) : 15N - 15N
  • [3] Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging
    Baker, Suzanne L.
    Lockhart, Samuel N.
    Price, Julie C.
    He, Mark
    Huesman, Ronald H.
    Schonhaut, Daniel
    Faria, Jamie
    Rabinovici, Gil
    Jagust, William J.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (02) : 332 - 338
  • [4] 18F-AV-1451 PET Correlations with Braak Tau Staging
    不详
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (05) : 20N - 21N
  • [5] 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers
    Smith, Ruben
    Puschmann, Andreas
    Scholl, Michael
    Ohlsson, Tomas
    van Swieten, John
    Honer, Michael
    Englund, Elisabet
    Hansson, Oskar
    [J]. BRAIN, 2016, 139 : 2372 - 2379
  • [6] Evaluation of Partial Volume Correction on Quantitation of the PET Tau Tracer, 18F-AV-1451
    Southekal, Sudeepti
    Dickson, James
    Joshi, Abhinay
    Navitsky, Michael
    Pontecorvo, Michael
    Lu, Ming
    Mintun, Mark
    Devous, Michael
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [7] Improved Syntheses of Reference Standard and Precursors for Tau Imaging Agent, [18F]AV-1451
    Horchler, Carey L.
    Clemens, Jennifer
    Hoye, Adam
    Li, Ximin
    Xiong, Hui
    Attardo, Giorgio
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2015, 58 : S262 - S262
  • [8] Pharmacokinetic Evaluation of the Tau PET Radiotracer 18F-T807 (18F-AV-1451) in Human Subjects
    Wooten, Dustin W.
    Guehl, Nicolas J.
    Verwer, Eline E.
    Shoup, Timothy M.
    Yokell, Daniel L.
    Zubcevik, Nevena
    Vasdev, Neil
    Zafonte, Ross D.
    Johnson, Keith A.
    El Fakhri, Georges
    Normandin, Marc D.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (03) : 484 - 491
  • [9] Modeling Strategies for Quantification of In Vivo 18F-AV-1451 Binding in Patients with Tau Pathology
    Hahn, Andreas
    Schain, Martin
    Erlandsson, Maria
    Sjolin, Petter
    James, Gregory M.
    Strandberg, Olof T.
    Hagerstrom, Douglas
    Lanzenberger, Rupert
    Jogi, Jonas
    Olsson, Tomas G.
    Smith, Ruben
    Hansson, Oskar
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (04) : 623 - 631
  • [10] In vivo retention of 18F-AV-1451 in corticobasal syndrome
    Smith, Ruben
    Scholl, Michael
    Widner, Hakan
    van Westen, Danielle
    Svenningsson, Per
    Hagerstrom, Douglas
    Ohlsson, Tomas
    Jogi, Jonas
    Nilsson, Christer
    Hansson, Oskar
    [J]. NEUROLOGY, 2017, 89 (08) : 845 - 853
12345